期刊文献+

HIV-2型gp105、gag核酸疫苗构建与免疫学研究

Construction and Immunolog of HIV-2 gp105 and/or gag DNA Vaccine
暂未订购
导出
摘要 目的 构建含 HIV-2 gp 105和 gag基因的核酸疫苗,并评价其免疫效果。方法 将 HIV-2 gp 105型和gag 基因克隆到核酸疫苗载体 pcDNA3.l(+)中,构建重组核酸疫苗质粒。通过间接免疫荧光试验在细胞水平上检测gp105和ggg基因的表达产物。重组核酸疫苗免疫小鼠后,用流式细胞仪测定CD4+、CD8+淋巴细胞亚类数,用HIV-2抗体ELISA检测试剂盒检测免疫鼠血清中抗HIV-2抗体。结果 构建了3种重组核酸疫苗质粒pcgag、pcgp105和pcgag-gp105-gp105,转染BHK细胞后都能表达外源蛋白,免疫小鼠后可有效地刺激淋巴细胞增殖,并诱导产生抗HIV-2特异性抗体,其中pcgag-gp105的免疫效果较pcgag和pcgp105显著。结论 构建的重组核酸疫苗质粒均能诱导机体产生免疫反应,含有融合基因的pcgag-gp105免疫效果最显著。 Abstract: Objective To construct DNA vaccines with HIV - 2 gp105 and gag genes and evaluate the immunological effect of them. Methods A recombinant DNA vaccine plasmid was constructed by cloning HIV - 2 gplOS and gag genes into vector pcDNA 3.1 ( + ). The expressed products of gplOS and gag genes were detected by indirect irnmunofluorescent assay. The CD4+ and CD8+ cells in spleens of mice immunized with the recombinant DNA vaccine were counted using Fluorescence Activated Cell Sorter, and the HIV - 2 antibodies in the sera of them were detected by ELISA kit. Results Three recombinant DNA vaccine plasmids, pcgag, pcgp105 and pcgag- gp105, were constructed. All of them expressed foreign protein after being transformed to BHK cells. The expressed products could stimulate the proliferation of T lymphocytes and induce HIV- 2 specific antibodies in mice. Compared with pcgag and pcgplOS, the immunological effect of pcgag-gplOS was more significant. Conclusion All the constructed recombinant DNA vaccine plasmids can induce immune responses, and that containing both gp105 and gag genes shows more significant effect.
出处 《中国生物制品学杂志》 CAS CSCD 2002年第1期9-12,共4页 Chinese Journal of Biologicals
基金 国家杰出青年基金项(3977O56661)资助
关键词 HIV-2 核酸疫苗 免疫学 gp105基因 GAG基因 HIV DNA vaccine Immunology
  • 相关文献

参考文献9

  • 1Rovinski B,Rodrigues L,Cao SX,et al.Induction of HIV type 1 neutralizing and env-CD4 blocking antibodies by immunization with genetically engineered HIV type 1-like particles containing unprocessed gp 160 glycoproteins.AIDS Res Hum Retro,1995,11:1187-1195.
  • 2Mcknight A,Shotton C,Cordell J,et al.Location exposure,and conservation of meutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.J Virol,1996,70:4598-4606.
  • 3金宁一.HIV基因结构及其疫苗研究[J].中国病毒学,1997,12(4):285-294. 被引量:6
  • 4Burton DR,Montefiori DC.The antibody response in HIV-1 infection.AIDS(sappl),1997, 11:87-98.
  • 5Sambrook J,Fritsch EF,Maniatis T.Molecular Cloning:A laboratory Manul.2nd ed.New Yourk:Cold Spring,Harbor Laboratory press,1989.
  • 6Lewis PJ,Babiuk LA.DNA vaccines:a review.Adv virus Res,1999,54:129-188.
  • 7Rodriguez F,Whitton JL.Enhancing DNA immunization.Virol,2000,268:233-238.
  • 8Yasutomi Y,Robinson HL,Lu S,et al.Siman immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.J Virol,1996,70(1):678-681.
  • 9Tobin GJ,Li GH,Fony SE,et al.Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshife elicit Gag-and Su-specific murine cytotoxic T-lymphocyte activities.Virology,1997,236(2):307-315.

二级参考文献3

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部